Sales Executive

Crossing Hurdles; San Francisco (CA); On-site; USD 120,000 - 260,000; Full time

Job summary

Crossing Hurdles, a global recruitment firm, partners with a high-growth startup building AI-driven compliance analysts that automate KYC/AML risk reviews for banks and fintechs.

The role is the first full GTM hire, requires 5+ years in GTM at a fast-growing company, and offers a path to shape the sales org. You will own $50K deals with a base salary of 100–200K plus 50% commission, reporting to the CEO.

Qualifications

• 5+ years of GTM experience at a high-growth startup.

Skills

GTM

Enterprise sales

Closing deals

Job description

Crossing Hurdles is a global recruitment firm partnering with a high-growth startup building AI‑driven compliance analysts that automate critical Know Your Customer (KYC), Anti‑Money Laundering (AML) and risk review work for banks, fintechs, crypto platforms, and other regulated teams.

Role Snapshot

• Role: GTM
• YOE: 5+ years of experience in a GTM role at a high- growth startup

About Clint

Our client builds AI analysts that automate AML/KYC compliance for banks and fintechs, replacing manual reviews with intelligent agents that assess risk, resolve alerts, and generate audit-ready decisions. Their platform integrates easily into existing workflows, helping teams onboard customers faster while cutting operational costs. By handling the majority of routine compliance work, they enable human analysts to focus on complex cases bringing modern AI infrastructure to one of the largest, most regulated markets.

Why candidates should join

• AI-Driven Impact: Join a team where Sphinx automates 90% of AML/KYC work, cutting costs 4x.
• High-Growth Momentum: Part of a $1M-revenue startup scaling fast in a $200B market.
• First Sales Hire: Work directly with the CEO and shape the sales org from the ground up.
• Competitive Edge: Beating Series B competitors in every RFP with no lost deals.
• Full-Cycle GTM Role: Own $50K deals with 100–200K base + 50% commission, clear path to CRO.